NCT00265200View on ClinicalTrials.gov

Using TRAP to Evaluate the Effect of Zometa on Bone Metastasis Due to Lung Cancer

PHASE2TerminatedINTERVENTIONAL

Enrollment

28

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

August 31, 2009

Study Completion Date

December 31, 2010

Conditions

Carcinoma, Non-Small Cell LungCarcinoma, Small Cell LungMetastases

Interventions

DRUG

zoledronic acid

3.0-4.0 mg by IV (in the vein), once a month for 6 months

Trial Locations (1)

40202

James Graham Brown Cancer Center, Louisville

Sponsors

Collaborators (1)

Novartis Pharmaceuticals

All Listed Sponsors

collaborator

James Graham Brown Cancer Center

OTHER

collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

University of Louisville

OTHER